What Men Should Know About BRCA Variant Testing

The genetic test Angelina Jolie helped make famous isn’t just for women. Certain at-risk men should consider it, too.

1:00 PM

Author | Michelle Jacobs, M.S., C.G.C.

In 2013, actress Angelina Jolie brought genetic testing for hereditary breast and ovarian cancer syndrome (HBOC) into the limelight by announcing that she had preventive surgery to remove her breasts. Last year, she announced another surgery to remove her ovaries and fallopian tubes.

SEE ALSO: Men with Prostate Cancer Should Have Genetic Testing, Study Says

Guiding her decision was a blood test that showed she was at increased risk of developing breast and ovarian cancer.

These declarations, which received wide media coverage, spurred many women to examine their family histories and their own cancer risks more closely, prompting some to seek genetic counseling.

However, discussion of the impact on men and their families has been largely absent, even though the condition affects both genders.

An inherited cancer syndrome, HBOC causes an increased risk of certain types of cancers — including ovarian cancer in women, prostate cancer in men, and breast and pancreatic cancer and melanoma in both genders.

HBOC is caused by mutations, or alterations, in the BRCA1 and BRCA2 genes. Such mutations are present in about 1 in 400 to 1 in 800 individuals, regardless of gender, and are more common in people of Ashkenazi Jewish descent (about 1 in 40).

Here are some common questions men might have about the need for and mechanics of such testing:

Which men should consider genetic testing for BRCA1 and BRCA2?

  • Those with personal or family history of male breast cancer

  • Those with personal or family history of at least two men with aggressive prostate cancers (Gleason score of 7 or greater)

  • Men with a family history of ovarian cancer; a female relative who developed breast cancer at a young age (earlier than 50) or developed multiple primary breast cancers; or three or more female relatives with breast cancer at any age

  • Men of Ashkenazi Jewish descent and personal or family history of breast, ovarian, or pancreatic cancers, aggressive prostate cancer, or melanoma

  • Those with known family history of a BRCA1 or BRCA2 mutation

How does genetic testing work?

At a genetic counseling appointment, a counselor and physician will collect family and personal history information from you to determine whether genetic testing may be a good option. If indicated, genetic testing is done via blood test.

What does it mean to have a BRCA1 or BRCA2 mutation?

Having a mutation in one of these genes does not mean a person will definitely develop cancer over his or her lifetime.

SEE ALSO: With Radiation Therapy, It Pays to Stay on Schedule

However, it does indicate an increased risk of cancer. Your health care team may recommend enhanced screening or prophylactic surgery. You can discuss this risk and options for management with a genetic counselor or a qualified physician.

Can men transmit this condition to their daughters?

Yes. Contrary to conventional thinking, each child of a man who has a BRCA1 or BRCA2 mutation has a 50 percent risk of carrying the same mutation, even if the man never develops cancer.

Regardless of whether you think you might change your own medical management based on these results, genetic testing can provide helpful information for relatives who may be at increased risk.

If your personal or family history is consistent with any of the above and you are interested in making an appointment for genetic counseling, the National Society of Genetic Counselors maintains a searchable database to help locate services in your area.


More Articles About: Preventative health and wellness BRCA gene Cancer and Genetics Cancer: Help, Diagnosis & Treatment
Health Lab word mark overlaying blue cells
Health Lab

Explore a variety of healthcare news & stories by visiting the Health Lab home page for more articles.

Media Contact Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Subscribe
Featured News & Stories Microscopic image of bone marrow with pink and white hues
Health Lab
Novel risk score for cardiovascular complications after bone marrow transplant
More bone marrow transplants, also known as hematopoietic stem cell transplantation, are being offered to older patients, a population at greater risk of cardiovascular disease.
cancer cell blue yellow
Health Lab
Less chemoradiation is possible for some cancer patients
Some oropharynx cancer patients may qualify for less radiation treatments, according to a new study from experts at the University of Michigan Health Rogel Cancer Center.
cancer cell blue yellow
Health Lab
Targeted drug shows promising ability in treating rare head and neck cancers
Experts at Rogel Cancer Center develop and study the impact of a new drug for salivary gland cancers
Drawing of parent trying to get child's attention who is listening to music on headphones
Health Lab
Are headphones and earbuds exposing your children to noise health risks?
2 in 3 parents in national poll say their child ages 5-12 use personal audio devices; pediatrician offers 4 tips to reduce noise exposure risks
Health care provider with stethoscope holds patient's hand
Health Lab
Combatting prostate cancer stigma
Prostate cancer is highly treatable and over 98% of men survive 10 years if the cancer is diagnosed and treated early.
patient end of bed in hospital looking out window with stuffed animal on bed
Health Lab
Studying cells to improve medulloblastoma treatment
Research from Michigan Medicine experts is shedding light and potentially expanding options for patients living with an aggressive childhood cancer.